When was CMR Naviscan founded?

CMR Naviscan was founded in 1995 and raised its 1st funding round 10 years after it was founded.

Where is CMR Naviscan located?

CMR Naviscan is headquartered in San Diego, United States.

Who is the current CEO of CMR Naviscan?

Paul Mirabella of CMR Naviscan.

How many employees does CMR Naviscan have?

As of Jul 31, 2026, the latest employee count at CMR Naviscan is 21.

Is CMR Naviscan a funded company?

CMR Naviscan is a funded company, having raised a total of $29.8M across 8 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Nov 28, 2005.

When was the latest funding round of CMR Naviscan?

CMR Naviscan's latest funding was a $***** Series E round on Dec 18, 2012, with participation from 0 investor. Its primary sector is Oncology. In United States, the Oncology sector has seen $3.79B in funding in 2026 to date.

Where does CMR Naviscan rank among its competitors?

CMR Naviscan ranks 9th amongst 61 active competitors, of which 15 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was QT Imaging, which secured $18M in Oct, 2025.

Who are the top competitors of CMR Naviscan?

CMR Naviscan's top competitors include Wixsite, QT Imaging and Vayyar. Among them, QT Imaging secured the most recent funding round in October, 2025.

CMR Naviscan - 2026 Company Profile, Team, Funding & Competitors

CMR Naviscan is an acquired company based in San Diego (United States), founded in 1995. It operates as a Develops and manufactures organ-specific molecular imaging technology solutions.. CMR Naviscan has raised $29.8M in funding from QuestMark Partners and Sanderling Ventures. The company has 61 active competitors, including 15 funded and 7 that have exited. Its top competitors include companies like Wixsite, QT Imaging and Vayyar.

Company Details

Naviscan, renamed as CMR Naviscan after its acquisition by CMR in 2013, provides systems for organ-specific molecular imaging. The company designs, manufactures, and distributes a high-resolution positron emission tomography (PET) scanner which provides visualization of small body parts. It offers a suite of products to aid in the detection and monitoring of breast cancer. The Naviscan Solo II High-Resolution Breast PET Scanner System in treatment monitoring and/or surgical planning for pre and post-treatment patients. Stereo Navigator (based on PET) to perform biopsies. And the MIMViewer which is an integrated platform for Breast PET viewing and analysis.

Website: naviscan.com
Email ID: *****@cmr-naviscan.com
Phone Number: +1 **********

Key Metrics

Founded Year

1995

Location

San Diego, United States

Stage

Acquired

Total Funding

$29.8M in 8 rounds

Latest Funding Round

Series E, Dec 18, 2012, $*****

Investors

QuestMark Partners & 3 more

Ranked

9^th among 61 active competitors

Employee Count

21 as on Jul 31, 2026

Similar Companies

Wixsite & 68 more

Exit Details

Acquired by CMR (Dec 11, 2013)

View CMR Naviscan's full profile

CMR Naviscan is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NAVISCAN, INC. CIN: 521949339 , United States, Active	Dec 31, 1999	-	-	-

CMR Naviscan got acquired by CMR on Dec 11, 2013.

Click here to take a look at CMR Naviscan's acquisition in detail

CMR Naviscan has raised a total funding of $29.8M over 8 rounds. Its first funding round was on Nov 28, 2005. CMR Naviscan has 4 institutional investors.

Here is the list of recent funding rounds of CMR Naviscan:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 18, 2012	3933905	Series E	3709422	1633548	6849088	7579355
Oct 14, 2011	4141523	Series E	7898556	1248460	9826333	6378868
Jun 09, 2010	1715198	Series E	9506082	9250227	9035844	4547013

Access funding benchmarks and valuations. Sign up today!

View details of CMR Naviscan's funding rounds and investors

CMR Naviscan's employee count trend

CMR Naviscan has 21 employees as of Jul 26. Here is CMR Naviscan's employee count trend over the years:

Uncover CMR Naviscan's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CMR Naviscan include Wixsite, QT Imaging and Vayyar. Here is the list of Top 10 competitors of CMR Naviscan, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Wixsite 2012, Norway, Deadpooled	Provider of tools enabling users to create and manage websites	-	WatchTower & Friends, JLABS & 9 others	61/100
2nd	QT Imaging 2012, Novato (United States), Public	Developer of a non-invasive ultrasound imaging device for detecting breast cancer	$28.8M	GigCapital, Proud.Ventures & 4 others	59/100
3rd	Vayyar 2011, Yehud (Israel), Series E	Developer of 4D imaging sensors for cancer detection and other devices	$296M	Celesta Capital, Koch Disruptive Technologies ... & 17 others	55/100
4th	Koning 2002, United States, Funding Raised	Innovating breast imaging with advanced 3D CT technology	-	Defense.gov, National Cancer Institute & 5 others	54/100
5th	CairnSurgical 2015, Lebanon (United States), Series A	Developer of 3D printed surgical guides for breast cancer treatment	$7.79M	Morningside Ventures, Morningside & 5 others	54/100
6th	Delphinus Medical Technologies 2010, Plymouth (United States), Series D	Platform for breast ultrasound imaging	$137M	Venture Investors, Beringea & 11 others	51/100
7th	Olive Healthcare 2016, Seoul (South Korea), Series B	Provider of device for wellness and medical purpose	$10.2M	Partners Investment, Korea Investment Holdings ... & 9 others	48/100
8th	UE LifeSciences 2009, Philadelphia (United States), Series A	Provider of a non-invasive breast cancer scanning device	$4.76M	Aarin Capital, Capria & 3 others	47/100
9th	CMR Naviscan 1995, San Diego (United States), Acquired	Develops and manufactures organ-specific molecular imaging technology solutions.	$29.8M	QuestMark Partners, Mayo Clinic Business Accelerator ... & 2 others	45/100
10th	Micrima 2005, Bristol (United Kingdom), Series A	Provider of non-invasive and a non-ionizing radio wave technology for detecting breast cancer.	$24.4M	ACF Investors, VentureFounders & 26 others	45/100